We only have this paper's title and publication details.
Read it at the sourceAnalysis reveals the proportion of metastatic cervical cancer patients tested for biomarkers, indicating treatment gaps.
Figure S2 shows the proportion of mCC patients tested for various biomarkers
No takes yet. Share an insight, caveat, or question.
Goh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: